Cationic lipids as one-component vaccine adjuvants: A promising alternative to alum
M Pizzuto, P Bigey, AM Lachagès, C Hoffmann… - Journal of controlled …, 2018 - Elsevier
Effective vaccine formulations consist of several components: an antigen carrier, the antigen,
a stimulator of cellular immunity such as a Toll-like Receptors (TLRs) ligand, and a …
a stimulator of cellular immunity such as a Toll-like Receptors (TLRs) ligand, and a …
Cationic lipids as one-component vaccine adjuvants: A promising alternative to alum
M Pizzuto, P Bigey, AM Lachages… - Journal of Controlled …, 2018 - hal.science
Effective vaccine formulations consist of several components: an antigen carrier, the antigen,
a stimulator of cellular immunity such as a Toll-like Receptors (TLRs) ligand, and a …
a stimulator of cellular immunity such as a Toll-like Receptors (TLRs) ligand, and a …
[引用][C] Cationic lipids as one-component vaccine adjuvants: a promising alternative to alum
M Pizzuto, P Bigey, AM Lachagès… - Journal of …, 2018 - espace.library.uq.edu.au
Effective vaccine formulations consist of several components: an antigen carrier, the antigen,
a stimulator of cellular immunity such as a Toll-like Receptors (TLRs) ligand, and a …
a stimulator of cellular immunity such as a Toll-like Receptors (TLRs) ligand, and a …
[PDF][PDF] Cationic lipids as one-component vaccine adjuvants: A promising alternative to alum
M Pizzuto, P Bigey, AM Lachagès… - Journal of Controlled …, 2018 - dipot.ulb.ac.be
Effective vaccine formulations consist of several components: an antigen carrier, the antigen,
a stimulator of cellular immunity such as a Toll-like Receptors (TLRs) ligand, and a …
a stimulator of cellular immunity such as a Toll-like Receptors (TLRs) ligand, and a …
Cationic lipids as one-component vaccine adjuvants: A promising alternative to alum
M Pizzuto, P Bigey, AM Lachagès… - … : official journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Effective vaccine formulations consist of several components: an antigen carrier, the antigen,
a stimulator of cellular immunity such as a Toll-like Receptors (TLRs) ligand, and a …
a stimulator of cellular immunity such as a Toll-like Receptors (TLRs) ligand, and a …
[引用][C] Cationic lipids as one-component vaccine adjuvants: A promising alternative to alum.
M Pizzuto, P Bigey, AM Lachagès… - Journal of controlled …, 2018 - difusion.ulb.ac.be
[引用][C] Cationic lipids as one-component vaccine adjuvants: A promising alternative to alum
M Pizzuto, P Bigey, AM Lachagès, C Hoffmann… - Journal of Controlled …, 2018 - cir.nii.ac.jp
Cationic lipids as one-component vaccine adjuvants: A promising alternative to alum | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Cationic lipids as one-component vaccine adjuvants: A promising alternative to alum.
M Pizzuto, P Bigey, AM Lachagès… - Journal of Controlled …, 2018 - europepmc.org
Effective vaccine formulations consist of several components: an antigen carrier, the antigen,
a stimulator of cellular immunity such as a Toll-like Receptors (TLRs) ligand, and a …
a stimulator of cellular immunity such as a Toll-like Receptors (TLRs) ligand, and a …
Cationic lipids as one-component vaccine adjuvants: A promising alternative to alum
M Pizzuto, P Bigey, AM Lachages… - Journal of Controlled …, 2018 - cnrs.hal.science
Effective vaccine formulations consist of several components: an antigen carrier, the antigen,
a stimulator of cellular immunity such as a Toll-like Receptors (TLRs) ligand, and a …
a stimulator of cellular immunity such as a Toll-like Receptors (TLRs) ligand, and a …